Abstract:Hyperhomocysteinemia (HHcy) has been shown to promote vascular inflammation and atherosclerosis, but the underlying mechanisms remain largely unknown. The NLRP3 inflammasome has been identified as the cellular machinery responsible for activation of inflammatory processes. In this study, we hypothesized that the activation of NLRP3 inflammasomes contributes to HHcy-induced inflammation and atherosclerosis. ApoE −/− mice were fed regular chow, high-fat (HF) diet, or HF plus high methionine diet to induce HHcy. To assess the role of NLRP3 inflammasomes in HHcy-aggravated atherosclerosis, NLRP3 shRNA viral suspension was injected via tail vein to knock down the NLRP3 gene. Increased plasma levels of IL-1 β and IL-18, aggravated macrophage infiltration into atherosclerotic lesions, and accelerated development of atherosclerosis were detected in HHcy mice as compared with control mice, and were associated with the activation of NLRP3 inflammasomes. Silencing the NLRP3 gene significantly suppressed NLRP3 inflammasome activation, reduced plasma levels of proinflammatory cytokines, attenuated macrophage infiltration and improved HHcy-induced atherosclerosis. We also examined the effect of homocysteine (Hcy) on NLRP3 inflammasome activation in THP-1-differentiated macrophages in the presence or absence of NLRP3 siRNA or the caspase-1 inhibitor Z-WEHD-FMK. We found that Hcy activated NLRP3 inflammasomes and promoted subsequent production of IL-1 β and IL-18 in macrophages, which were blocked by NLRP3 gene silencing or Z-WEHD-FMK. As reactive oxygen species (ROS) may have a central role in NLRP3 inflammasome activation, we next investigated whether antioxidant N -acetyl- l -cysteine (NAC) prevented Hcy-induced NLRP3 inflammasome activation in macrophages. We found Hcy-induced NLRP3 inflammasome activation was abolished by NAC. Treatment with NAC in HHcy mice also suppressed NLRP3 inflammasome activation and improved HHcy-induced atherosclerosis. These data suggest that the activation of NLRP3 inflammasomes contributes to HHcy-aggravated inflammation and atherosclerosis in apoE −/− mice. Hcy activates NLRP3 inflammasomes in ROS-dependent pathway in macrophages. These results may have implication for the treatment of HHcy-associated cardiovascular diseases.

Mir‐34a Targets HDAC1‐Regulated H3K9 Acetylation on Lipid Accumulation Induced by Homocysteine in Foam Cells

Hyperhomocysteinemia in Apoe-/- Mice Leads to Overexpression of Enhancer of Zeste Homolog 2 Via Mir-92a Regulation

Homocysteine-Mediated Cholesterol Efflux Via Abca1 and Acat1 Dna Methylation in Thp-1 Monocyte-Derived Foam Cells

Homocysteine accelerates atherosclerosis via inhibiting LXRα–mediated ABCA1/ABCG1–dependent cholesterol efflux from macrophages

Reciprocal Regulation Between Mir-148A/152 and DNA Methyltransferase 1 is Associated with Hyperhomocysteinemia-Accelerated Atherosclerosis

Elevated MicroRNA-155 Targets HBP1 to Promote the Formation of Macrophage-Derived Foam Cell and This Can Be Effectively Suppressed by YY1/HDACs Complex

Involvement of Histone Methylation in Macrophage Apoptosis and Unstable Plaque Formation in Methionine-Induced Hyperhomocysteinemic Apoe(-/-) Mice

miR‐195‐3p alleviates homocysteine‐mediated atherosclerosis by targeting IL‐31 through its epigenetics modifications

[The Effect of Mir-124 on Homocysteine-Induced Atherosclerosis Via Promoter Region DNA Methylation in ApoE(-/-) Mice].

High-methionine Diets Accelerate Atherosclerosis by HHcy-mediated FABP4 Gene Demethylation Pathway Via DNMT1 in ApoE(-/-) Mice.

Homocysteine affects macrophage polarization by altering m6A methylation of scavenger receptors CD209 and CD163L1

Homocysteine Accelerates Atherosclerosis by Inhibiting Scavenger Receptor Class B Member1 Via DNMT3b/SP1 Pathway.

Activation of NLRP3 Inflammasomes Contributes to Hyperhomocysteinemia-Aggravated Inflammation and Atherosclerosis in Apoe-Deficient Mice.

Hyperhomocysteinemia Decreases Circulating High-Density Lipoprotein by Inhibiting Apolipoprotein A-I Protein Synthesis and Enhancing HDL Cholesterol Clearance

Interfering Microrna-410 Attenuates Atherosclerosis Via the HDAC1/KLF5/IKBα/NF-κB Axis

The Influence of Homocysteine on the Expressions of ABCA1 and ACAT1 in the Formation of THP-1monocyte-derived Foam Cells

Enhancing PPARγ by HDAC Inhibition Reduces Foam Cell Formation and Atherosclerosis in ApoE Deficient Mice

Homocysteine promotes hepatic steatosis by activating the adipocyte lipolysis in a HIF1α-ERO1α-dependent oxidative stress manner

Elevated Microrna-155 Promotes Foam Cell Formation By Targeting Hbp1 In Atherogenesis

Homocysteine Induces 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Vascular Endothelial Cells

Hcy promotes the formation of atherosclerotic and effect of liver lipid metabolism disorder in ApoE-/- mice